Wellmune is a purified baker's-yeast fiber taken daily to keep first-line immune defenses primed. Its most consistent benefit is fewer and milder colds and upper-airway infections, alongside better energy and mood under strain. Evidence is moderate, often industry-funded and based on self-reported symptoms; side effects are rare and mild. (Full Review)

Protocol

Standard Dose

250 mg / day

Once daily; most evidence-backed regimen for respiratory and mood/energy outcomes

Higher Dose

500 mg / day

When targeting vaccine response or in older adults; added benefit over 250 mg not firmly established

Timing

Morning, with food

Timing not critical; single daily dose; with food for tolerability

Time to effect

Infection Prevention

Weeks–3 months

Most trials dose several weeks to 3 months before assessing infection outcomes

Mood & Energy

Multi-week

Mood and energy changes measured over similar multi-week periods

Fair Trial

4–12 weeks

Minimum period to give the intervention a fair trial

Benefits

Medium: Reduced incidence and duration of upper respiratory tract infections; reduced severity of cold/flu symptoms; improved mood, vigor, and reduced fatigue

Low: Enhanced vaccine antibody response; markers of innate immune activation

Speculative: Metabolic and blood-sugar support; allergy and airway hypersensitivity modulation

Contraindications

Deliberate immunosuppression (organ-transplant recipients)

Active autoimmune disease (theoretical)

Pregnancy or breastfeeding (limited safety data)

Key Interactions

Immunosuppressant drugs (corticosteroids, calcineurin inhibitors, TNF biologics)

Other immune-stimulating supplements (echinacea, AHCC, mushroom or yeast glucans)

Risk & Side Effects

Low: Mild gastrointestinal discomfort

Speculative: Theoretical concern in autoimmune or inflammatory conditions; yeast sensitivity or allergy reactions; immune over-activation after intense exercise

Monitoring

Marker	Target	Why
25-hydroxyvitamin D	40–60 ng/mL	Underpins innate immunity; often co-supplemented with beta-glucan
High-sensitivity CRP (hs-CRP)	< 1.0 mg/L	Tracks general inflammation; watches the theoretical immune-activation concern
Complete blood count with differential (CBC)	Within normal limits, stable	Monitors monocytes/neutrophils that Wellmune may modestly shift
Fasting glucose / HbA1c	Glucose 75–90 mg/dL; HbA1c < 5.4%	Relevant if using beta-glucan for the speculative metabolic benefit

Cadence: Baseline, optional check at 4–12 weeks, then every 6–12 months or seasonally

Qualitative Assessment

Frequency and severity of colds or upper respiratory infections across a season
Number of sick days or missed workouts/work days
Daily energy and vigor
Mood and sense of well-being, especially during high-stress periods
Recovery speed when an infection does occur

Wellmune for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment